Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.08 | -$0.08 | -$0.08 |
Q2 2024 | 3 | -$0.07 | -$0.06 | -$0.07 |
Q3 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q4 2024 | 2 | -$0.05 | -$0.02 | -$0.03 |
Q1 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
Q2 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
Q3 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
Q4 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q1 2026 | 1 | $0.01 | $0.02 | $0.02 |
Q2 2026 | 1 | $0.01 | $0.01 | $0.01 |
Q3 2026 | 1 | $0.01 | $0.01 | $0.01 |
Q4 2026 | 1 | $0.02 | $0.02 | $0.02 |
LifeStance Health Group, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.02 earnings per share for the quarter, topping analysts' consensus estimates of $-0.07 by $0.05. The company had revenue of 312.72 M for the quarter and had revenue of 1.06 B for the year. LifeStance Health Group, Inc. has generated $-1 earnings per share over the last year ($-0.51 diluted earnings per share) and currently has a price-to-earnings ratio of -29.77. LifeStance Health Group, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$0.07 | -$0.02 | 0.05 | $302.25 M | $312.72 M |
08/08/2024 | Q2 2024 | -$0.07 | -$0.06 | 0.01 | $305.85 M | $312.33 M |
05/09/2024 | Q1 2024 | -$0.09 | -$0.06 | 0.03 | $300.44 M | |
12/29/2023 | Q4 2023 | -$0.12 | $280.60 M | |||
11/08/2023 | Q3 2023 | -$0.07 | -$0.17 | -0.1 | $255.18 M | $262.90 M |
08/09/2023 | Q2 2023 | -$0.09 | -$0.13 | -0.04 | $255.19 M | $259.58 M |
05/10/2023 | Q1 2023 | -$0.11 | -$0.09 | 0.02 | $252.59 M | |
03/09/2023 | Q4 2022 | -$0.12 | $229.36 M | |||
11/09/2022 | Q3 2022 | -$0.11 | $219.16 M | $217.56 M | ||
08/10/2022 | Q2 2022 | -$0.19 | $212.24 M | $209.53 M | ||
05/11/2022 | Q1 2022 | -$0.18 | $203.10 M | |||
03/17/2022 | Q4 2021 | -$0.33 | $190.00 M | |||
11/10/2021 | Q3 2021 | -$0.35 | $171.31 M | $173.84 M | ||
08/11/2021 | Q2 2021 | -$0.22 | $155.99 M | $160.55 M | ||
03/31/2021 | Q1 2021 | -$0.02 | $143.13 M | |||
12/31/2020 | Q4 2020 | -$0.02 | $118.12 M | |||
09/30/2020 | Q3 2020 | -$0.01 | $101.98 M | |||
06/30/2020 | Q2 2020 | -$0.01 | $45.45 M | |||
03/31/2020 | Q1 2020 | $0.01 | $73.11 M |
LifeStance Health Group, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
In the previous quarter, LifeStance Health Group, Inc. (:LFST) reported $-0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.07 by $0.05.
The conference call for LifeStance Health Group, Inc.'s latest earnings report can be listened to online.
The conference call transcript for LifeStance Health Group, Inc.'s latest earnings report can be read online.
LifeStance Health Group, Inc. (:LFST) has a recorded annual revenue of $1.06 B.
LifeStance Health Group, Inc. (:LFST) has a recorded net income of $1.06 B. LifeStance Health Group, Inc. has generated $-0.51 earnings per share over the last four quarters.
LifeStance Health Group, Inc. (:LFST) has a price-to-earnings ratio of -29.77 and price/earnings-to-growth ratio is -0.76.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED